DNM1L-related disorders are associated with neonatal or infantile-onset encephalopathy with varying severity degrees of refractory epilepsy, hypotonia and cognitive impairment dependent on the specific causative variant. This evidence concerns the gene DNM1L and Cognitive impairment.